Yubo Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yubo Sun has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Chunhua Deng
Department of Urology and Andrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
1 shared publication - Chunyan Wang
Department of Nephrology, Children’s Hospital of Fudan University, Shanghai Kidney Development and Pediatric Kidney Disease Research Center, Shanghai, China
1 shared publication - Dan Xia
Department of Urology, Institute of Urologic Science and Technology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication - Ding Peng
Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication - Fangjian Zhou
Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, China
1 shared publication - Feng Liu
Department of Nephrology, Children’s Hospital of Fudan University, Shanghai Kidney Development and Pediatric Kidney Disease Research Center, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 13 April 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (5) , e1938
Effect of Donor-recipient Size on Graft Growth in Pediatric Donor-to-pediatric Recipient Kidney Transplantation
Background.: Kidney transplantation is the optimal treatment for pediatric end-stage kidney disease, yet donor shortages have driven the use of pediatric donor kidneys through pediatric donor-to-pediatric recipient (PTP) kidney transplantation. This study aimed to investigate the effect of donor-recipient size on graft growth in PTP kidney transplantation. Methods.: This retrospective cohort study included kidney transplant recipients who underwent regular follow-ups between January 2016 and December 2023 at the Children’s Hospital of Fudan University. All donors were deceased and aged P < 0.01). The mean estimated glomerular filtration rate at the last follow-up was 84.1 ± 31.8 mL/min/1.73 m 2 . Posttransplant estimated glomerular filtration rate showed a significant positive correlation with donor-recipient body weight ratio during the early posttransplant period (1, 3, and 6 mo; P < 0.01). Smaller grafts required approximately 6 mo to reach a normative size consistent with the recipients’ age. Conclusions.: Grafts showed stable growth patterns and favorable short-term follow-up outcomes. Additionally, PTP kidney transplantation demonstrated both clinical value and practical utility.
- 13 April 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (5) , e1938
Open AccessEffect of Donor-recipient Size on Graft Growth in Pediatric Donor-to-pediatric Recipient Kidney Transplantation
Background.: Kidney transplantation is the optimal treatment for pediatric end-stage kidney disease, yet donor shortages have driven the use of pediatric donor kidneys through pediatric donor-to-pediatric recipient (PTP) kidney transplantation. This study aimed to investigate the effect of donor-recipient size on graft growth in PTP kidney transplantation. Methods.: This retrospective cohort study included kidney transplant recipients who underwent regular follow-ups between January 2016 and December 2023 at the Children’s Hospital of Fudan University. All donors were deceased and aged P < 0.01). The mean estimated glomerular filtration rate at the last follow-up was 84.1 ± 31.8 mL/min/1.73 m 2 . Posttransplant estimated glomerular filtration rate showed a significant positive correlation with donor-recipient body weight ratio during the early posttransplant period (1, 3, and 6 mo; P < 0.01). Smaller grafts required approximately 6 mo to reach a normative size consistent with the recipients’ age. Conclusions.: Grafts showed stable growth patterns and favorable short-term follow-up outcomes. Additionally, PTP kidney transplantation demonstrated both clinical value and practical utility.
- Open Access
- 21 September 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (12) , 4185-4198
SAVE Testis-sparing score: a multicenter retrospective study of a novel predictive tool for quantifying testicular tumors
Background: Testis-sparing surgery (TSS) is a safe treatment for patients with benign testicular tumors. Presently, assessments for evaluating the suitability of TSS are poorly standardized, partially because testicular anatomical elements cannot be quantitatively described. Materials and methods: The authors developed a scoring method known as the SAVE testis-sparing score based on four critical and accessible anatomical features of a testicular tumor. The SAVE score ranges from 0 to 8 and is divided into four risk classes (low, medium, high, and extremely high) to evaluate the feasibility of TSS, wherein low-risk indicates high feasibility and vice versa. This study included 444 testicular tumor patients from eight centers. Among them, 216 patients (model group: 151 patients, validation group: 65 patients) were included in the modeling analysis, and the other 228 patients from children’s centers were included in the proportion analysis. Using retrospective data, patient characteristics associated with surgical methods were identified. Furthermore, a multivariate logistic regression model was built quantify the associations between these characteristics and the surgery method. The receiver operator characteristic curve was used to evaluate the classification efficiency of SAVE. Results: The SAVE testis-sparing score includes size (tumor size as maximal diameter), available testicular tissue volume, volume ratio of the tumor to the testis, and the exophytic/endophytic properties of the tumor. The SAVE scoring system accurately classified the suitability of TSS based on the complexity of benign testicular tumors. Conclusion: The SAVE score is a reproducible and robust tool for quantitatively describing the anatomical characteristics of benign testicular tumors and guide the preoperative evaluation of TSS.
- 21 September 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (12) , 4185-4198
Open AccessSAVE Testis-sparing score: a multicenter retrospective study of a novel predictive tool for quantifying testicular tumors
Background: Testis-sparing surgery (TSS) is a safe treatment for patients with benign testicular tumors. Presently, assessments for evaluating the suitability of TSS are poorly standardized, partially because testicular anatomical elements cannot be quantitatively described. Materials and methods: The authors developed a scoring method known as the SAVE testis-sparing score based on four critical and accessible anatomical features of a testicular tumor. The SAVE score ranges from 0 to 8 and is divided into four risk classes (low, medium, high, and extremely high) to evaluate the feasibility of TSS, wherein low-risk indicates high feasibility and vice versa. This study included 444 testicular tumor patients from eight centers. Among them, 216 patients (model group: 151 patients, validation group: 65 patients) were included in the modeling analysis, and the other 228 patients from children’s centers were included in the proportion analysis. Using retrospective data, patient characteristics associated with surgical methods were identified. Furthermore, a multivariate logistic regression model was built quantify the associations between these characteristics and the surgery method. The receiver operator characteristic curve was used to evaluate the classification efficiency of SAVE. Results: The SAVE testis-sparing score includes size (tumor size as maximal diameter), available testicular tissue volume, volume ratio of the tumor to the testis, and the exophytic/endophytic properties of the tumor. The SAVE scoring system accurately classified the suitability of TSS based on the complexity of benign testicular tumors. Conclusion: The SAVE score is a reproducible and robust tool for quantitatively describing the anatomical characteristics of benign testicular tumors and guide the preoperative evaluation of TSS.